Retinal Morphology Changes Following Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

被引：0
|
作者：
Broadhead, Geoffrey [1 ,2 ]
Hong, Thomas [1 ]
Li, Haitao [1 ]
Zhu, Meidong [1 ,2 ]
Wijeyakumar, Wijeyanthy [1 ,2 ]
Chang, Andrew Alexander [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 552 imaging methods (CT; FA; ICG; MRI; OCT; RTA; SLO; ultrasound);
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3924
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
  • [2] INTRAVITREAL AFLIBERCEPT FOR TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 52 - 52
  • [3] CHANGES IN RETINAL MORPHOLOGY FOLLOWING INTRAVITREAL AFLIBERCEPT FOR TREATMENT RESISTANT AGE-RELATED MACULAR DEGENERATION
    Broadhead, Geoffrey K.
    Hong, Thomas
    Wijeyakumar, Wijeyanthy
    Li, Haitao
    Schlub, Timothy
    Zhu, Meidong
    Chang, Andrew A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 49 - 50
  • [4] Morphological changes with Intravitreal Aflibercept for Treatment Resistant Neovascular Age-Related Macular Degeneration
    Wong, Lily
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] RETINAL VASCULAR CHANGES IN TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS TREATED WITH AFLIBERCEPT
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    Hong, Thomas
    Broadhead, Geoffrey K.
    Chang, Andrew A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 113 - 114
  • [6] Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Gharbiya, Magda
    Iannetti, Ludovico
    Parisi, Francesco
    De Vico, Umberto
    Mungo, Maria Laura
    Marenco, Marco
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 2-year Outcomes
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Joachim, Nichole
    Wong, Lily
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [9] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [10] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345